HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

China

Anhui Provincial Hospital, Hefei, Anhui

The Second Hospital of Anhui Medical University, Hefei, Anhui

Peking University Third Hospital, Beijing, Beijing Municipality

The first affiliated hospital of Fujian medical university, Fuzhou, Fujian

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong